437
Participants
Start Date
June 30, 2021
Primary Completion Date
April 12, 2023
Study Completion Date
May 10, 2023
OXD01 digital therapy
OXD01 digital therapy, 1-2 times per week 15-30 minutes each time.
Standard of Care
Sublingual buprenorphine/naloxone Medication-assisted treatment, the current standard for opioid addiction; the use of medications in combination with counseling
Dr. Vando Medical Services PC, The Bronx
MD Medical Management, Kingston
Thalia Medical Center, Haverford
Medically Assisted Recovery Service, Philadelphia
Institute of Addiction Medicine, Plymouth Meeting
Humanity Clinical Research, Pembroke Pines
Parkway Medical Center, Birmingham
Precise Research Centers, Flowood
Otrimed Clinical Research, Edgewood
North Star Medical Research, Middleburg Heights
Neuro-Behavioral Clinical Research Center, North Canton
CincyScience, West Chester
Midwest Clinical Research Center, Dayton
Patient First Medical Clinic, Dearborn
Southern Illinois Associates LLC, Glen Carbon
PsychCare Consultants Research, St Louis
Pahl Pharmaceuticals Professions, Oklahoma City
Aspen Clinical Research, Orem
North County Clinical Research, Oceanside
Artemis Institute for Clinical Research, San Diego
Wetlin Research Associates, Inc, San Diego
Lead Sponsor
Orexo AB
INDUSTRY